Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus CHOP (R-CHOP) as the initial treatment for lymphoma. METHODS: A retro...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Lim, Kyu-Hyoung, Yoon, Ho-Il, Kang, Young Ae, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jae Ho, Lee, Choon-Taek, Lee, Jong Seok
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Korean Association of Internal Medicine 2010
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829422/
https://ncbi.nlm.nih.gov/pubmed/20195409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2010.25.1.86
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk